TWI799423B
(en )
2023-04-21
Freeze-free medicinal transport carriers
MY195009A
(en )
2022-12-30
Cellular Targeted Active Ingredient Delivery System
MY187540A
(en )
2021-09-28
Compounds active towards bromodomains
EP3160565A4
(en )
2018-04-18
Methods, devices and systems for pulmonary delivery of active agents
EP3160554A4
(en )
2018-04-18
Methods, devices and systems for pulmonary delivery of active agents
MX367326B
(en )
2019-08-15
Antimicrobial compositions.
PH12016501841A1
(en )
2017-01-09
Immunosuppressant formulation
EP3318282A4
(en )
2019-05-22
Drug delivery carrier, and composition containing same
EA033510B1
(en )
2019-10-31
Cineole-containing composition for nasal application
MX2015008486A
(en )
2015-09-10
Compositions and methods for treating bacterial infections.
IN2013MU01985A
(en )
2015-05-29
EP3190129A4
(en )
2017-09-13
Centrally-acting peptide derivative, and pharmaceutical composition
CA3011003A1
(en )
2017-07-27
Bacterial ghosts for the treatment of cancer
MX2016004078A
(en )
2016-06-06
Hiv treatment formulation of atazanavir and cobicistat.
MY183068A
(en )
2021-02-10
Pharmaceutical formulation comprising antibody
MX2018005350A
(en )
2018-08-14
Eflornithine and sulindac, fixed dose combination formulation.
HK1244275A1
(en )
2018-08-03
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same
PH12017500071A1
(en )
2017-05-15
Therapeutic agent for keratoconjunctive disorder
PH12018501991A1
(en )
2019-06-17
Pharmaceutical composition for use in treating fibrosis
GB2543709A
(en )
2017-04-26
Pharmaceutical agent
IN2013MU03370A
(en )
2015-09-25
UA89548U
(en )
2014-04-25
Pharmaceutical aerosol composition for treating bacterial vaginosis
EP3532068A4
(en )
2020-04-29
Mucosal active agent delivery
GEP20196989B
(en )
2019-07-10
Pharmaceutical composition comprising bisoprolol and perindoril
IN2014DE00111A
(en )
2015-07-17